Influence
April 1, 2025

Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs

Kosali Simon, PhD

Published in JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Kosali Simon, PhD, M.A.

This study examined how proximity to opioid treatment programs (OTPs) impacts methadone receipt among Medicare beneficiaries diagnosed with opioid use disorder (OUD) in 2020. Using Medicare claims and drive-time data, researchers found that methadone receipt decreased as distance to an OTP increased. Urban beneficiaries living within 5 minutes of an OTP were 54% more likely to receive methadone than those 15 minutes away; in rural areas, the drop was 27%. A threshold effect was observed at a 20-minute drive time, beyond which the likelihood of methadone receipt leveled off and showed minimal differences between urban and rural populations. The findings highlight the importance of OTP location in improving access to OUD treatment.

Authors

Jonathan Cantor 1Helin G Hernandez 1Aaron Kofner 2Julie Lai 1Denis Agniel 1Kosali I Simon 3Bradley D Stein 4Erin A Taylor 1

Affiliations

1RAND, Santa Monica, California.

2RAND, Arlington, Virginia.

3O’Neill School of Public and Environmental Affairs, Indiana University, Bloomington.

4RAND, Pittsburgh, Pennsylvania.

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time